Natural immunity to malaria preferentially targets the endothelial protein C receptor-binding regions of PfEMP1s.

Autor: Tewey MA; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland, USA., Coulibaly D; Malaria Research and Training Center, University of Sciences, Techniques and Technologies , Bamako, Mali., Lawton JG; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland, USA., Stucke EM; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland, USA., Zhou AE; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland, USA., Berry AA; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland, USA., Bailey JA; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland, USA., Pike A; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland, USA., Dara A; Malaria Research and Training Center, University of Sciences, Techniques and Technologies , Bamako, Mali., Ouattara A; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland, USA., Lyke KE; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland, USA., Ifeonu O; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland, USA., Laurens MB; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland, USA., Adams M; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland, USA., Takala-Harrison S; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland, USA., Niangaly A; Malaria Research and Training Center, University of Sciences, Techniques and Technologies , Bamako, Mali., Kouriba B; Malaria Research and Training Center, University of Sciences, Techniques and Technologies , Bamako, Mali., Koné AK; Malaria Research and Training Center, University of Sciences, Techniques and Technologies , Bamako, Mali., Rowe JA; Centre for Immunity, Infection and Evolution, Institute of Immunology and Infection Research, School of Biological Sciences, University of Edinburgh , Edinburgh, United Kingdom., Doumbo OK; Malaria Research and Training Center, University of Sciences, Techniques and Technologies , Bamako, Mali., Patel JJ; Roche NimbleGen, Inc. , Madison, Wisconsin, USA., Tan JC; Roche NimbleGen, Inc. , Madison, Wisconsin, USA., Felgner PL; Division of Infectious Diseases, Department of Medicine, University of California , Irvine, California, USA., Plowe CV; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland, USA., Thera MA; Malaria Research and Training Center, University of Sciences, Techniques and Technologies , Bamako, Mali., Travassos MA; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland, USA.

Publikováno v: MSphere [mSphere] 2023 Oct 24; Vol. 8 (5), pp. e0045123. Date of Electronic Publication: 2023 Oct 04.